“It was probably around 2013 or 2014 when I was at Monsanto that it became really clear that CRISPR was going to matter” for plant breeding, says Pairwise cofounder and CEO Dr. Tom Adams.
Regenerative agriculture delivers benefits to farmers, say Bayer and Perdue Agribusiness, but they don’t come overnight.
A few months ago, Bayer and Microsoft announced a partnership. Our article about it went quasi-viral and spurred a number of responses. Here’s what the industry said.
The agrifood industry wondered how Bayer would approach venture investing after its acquisition of Monsanto. Derek Norman talks with AFN about the company’s turn to impact investing.
Find out where and when exits will come, how startups can get acquisition-ready, and how the landscape is changing with Covid-19.
The facility is the first of its kind for the company and the most technically advanced, costing roughly $100 million for a company that has had a rough ride on its share price valuation over the last few years.
Although it’s interested in biologics, it claims farmers still need the high rate of efficacy that chemical agriculture has to offer.
Venture capital at Bayer Crop Science, which has until now focused mainly on investing in external funds, is just beginning to firm up with the creation of Bayer Growth Ventures (BGV). But there are still a lot of unknowns.
A few details about the future of venture capital at the new integrated Bayer have emerged, but according to Bayer Crop Science CEO Liam Condon, firm plans are still months away.
A new coalition of agriculture and finance industry players is working together to find new ways to get technology into the hand of smallholders farmers
Farmers Business Network makes an acquisition in Canada while Bayer sells assets to get ready for the big takeover, plus more in this week’s brief.
We caught up with Adrian Percy, global head of R&D for Crop Science at Bayer on the sidelines of the World Agri-Tech Innovation Summit, to discuss the company’s open innovation strategies in the area of biologicals and novel crop inputs.
Bayer and Ginkgo Bioworks announced the partnership in September 2017. The partners jointly invested $100 million in the venture, making the deal the second largest deal from an Ag Biotechnology startup in 2017, according to the AgFunder data.
The Climate Action 100+ initiative is the work of 225 investors with more than $26.3 trillion assets under management including banks, private equity firms, and pension funds to name a few.
Bayer CropScience and Ginkgo Bioworks, a startup genetically engineering microbes for the flavor, fragrance, and food industries, have partnered with hedge fund Viking Global Investors to invest $100 million in a new, as yet unnamed agtech startup.
SlantRange, a US drone sensor manufacturer and imagery analytics provider using computer vision for agriculture, has won a contract with Bayer CropScience’s crop breeding and research programs in the US.
We speak to Geoff Kneen, the R&D Licensing and new ventures manager, North America of Bayer’s Crop Science division, to hear more about Bayer’s strategy of outsourcing agtech investment.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first